Mission & Vision


ExCellThera will become a global leader in the development, manufacturing and distribution of expanded and genetically engineered hematopoietic stem cells for therapeutics with an initial focus on blood cancers and gene therapy.


  • To become the leading provider of expanded cord blood stem cells for transplant in acute myeloid leukemia.
  • To expand the market opportunity by addressing indications amenable to allogeneic hematopoietic stem cell transplants, including leukemias and lymphomas.
  • To engage and collaborate with industry partners and key opinion leaders to identify other commercial opportunities for development and/or licensing.